We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

112 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $2.41M | Put options by funds: $1.19M

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

2.21% more ownership

Funds ownership: 33.22% → 35.44% (+2.2%)

1% more funds holding

Funds holding: 111 → 112 (+1)

1% less capital invested

Capital invested by funds: $125M → $123M (-$1.86M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
112
Holders Change
+1
Holders Change %
+0.9%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
16
Increased
21
Reduced
25
Closed
12
Calls
$2.41M
Puts
$1.19M
Net Calls
+$1.22M
Net Calls Change
+$2.75M

Top Buyers

Rank Fund Capital Flow
1
AA
Ascent Advisors
Minnesota
+$11.5M
2
Bank of America
Bank of America
North Carolina
+$3.93M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.83M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$729K
5
Wells Fargo
Wells Fargo
California
+$667K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.03M
2
Corient Private Wealth
Corient Private Wealth
Florida
-$1.9M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.1M
4
LPL Financial
LPL Financial
California
-$1.01M
5
UBS Group
UBS Group
Switzerland
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$19.2M – – –
Raymond James Financial
2
Raymond James Financial
Florida
$13.1M -$472K -2,451 -3%
Bank of America
3
Bank of America
North Carolina
$12.5M +$3.93M +20,375 +44%
MIM
4
Miller Investment Management
Pennsylvania
$7.33M +$7.13K +37 +0.1%
Morgan Stanley
5
Morgan Stanley
New York
$6.19M -$5.03M -26,094 -44%
Wells Fargo
6
Wells Fargo
California
$6.17M +$667K +3,464 +12%
LPL Financial
7
LPL Financial
California
$4.99M -$1.01M -5,262 -17%
CCA
8
Conservest Capital Advisors
Pennsylvania
$3.81M +$729K +3,782 +23%
UBS Group
9
UBS Group
Switzerland
$3.12M -$690K -3,582 -18%
BFG
10
Bleakley Financial Group
New Jersey
$2.9M -$449K -2,329 -13%
PPWM
11
Paragon Private Wealth Management
Kentucky
$2.89M +$149K +775 +5%
AA
12
Ascent Advisors
Minnesota
$2.68M +$11.5M +59,450 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$2.6M +$109K +565 +4%
Rockefeller Capital Management
14
Rockefeller Capital Management
New York
$2.23M – – –
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$1.89M +$76.5K +397 +4%
Citadel Advisors
16
Citadel Advisors
Florida
$1.79M +$1.83M +9,514 New
LJAC
17
L.J. Altfest & Co
New York
$1.6M -$20.4K -106 -1%
IFWM
18
Institute for Wealth Management
Colorado
$1.4M -$6.55K -34 -0.5%
Stifel Financial
19
Stifel Financial
Missouri
$1.37M +$87.1K +452 +7%
PGFC
20
Peapack-Gladstone Financial Corp
New Jersey
$1.35M – – –
Wealthfront Advisers
21
Wealthfront Advisers
California
$1.32M +$287K +1,491 +27%
Ameriprise
22
Ameriprise
Minnesota
$1.23M +$26K +135 +2%
Two Sigma Investments
23
Two Sigma Investments
New York
$1.15M -$1.1M -5,700 -48%
Cerity Partners
24
Cerity Partners
New York
$1.04M -$46.6K -242 -4%
ACA
25
Atlas Capital Advisors
Wyoming
$1.02M -$48.2K -250 -4%
1
2 3 4 5

BBH Hedge Fund Activity: Q1 2026 in Review

112 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2026, worth a combined $123M — down 1.5% from $125M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 12 closed out — a net gain of 4 holders — while 21 added to existing stakes and 25 trimmed.

The largest buyer was Ascent Advisors, opening a new position worth an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $5.03M.

  • 112 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2026, up from 111 in Q4 2025.
  • Funds reported $123M of VanEck Biotech ETF stock for Q1 2026, down 1.5% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q1 2026 and 12 closed out, a net change of +4 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2026 was Ascent Advisors, an estimated $11.5M added.
  • The largest VanEck Biotech ETF seller in Q1 2026 was Morgan Stanley, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2026.